The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-{[(8-Hydroxyquinolin-5-yl)methyl]amino}-N-phenylpentanamide ID: ALA4580239
PubChem CID: 155565303
Max Phase: Preclinical
Molecular Formula: C21H23N3O2
Molecular Weight: 349.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCCCNCc1ccc(O)c2ncccc12)Nc1ccccc1
Standard InChI: InChI=1S/C21H23N3O2/c25-19-12-11-16(18-9-6-14-23-21(18)19)15-22-13-5-4-10-20(26)24-17-7-2-1-3-8-17/h1-3,6-9,11-12,14,22,25H,4-5,10,13,15H2,(H,24,26)
Standard InChI Key: KPZOFDQMVMCUIC-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
8.8049 -9.3835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5171 -9.7925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2281 -8.5562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2288 -9.3794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0969 -9.7915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3854 -9.3824 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6732 -9.7904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9617 -9.3813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2496 -9.7893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5381 -9.3801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8259 -9.7882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1144 -9.3790 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8253 -10.6095 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1150 -8.5577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8273 -8.1475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8283 -7.3269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1162 -6.9169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4059 -7.3294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4084 -8.1486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8061 -8.5598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5143 -8.1480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5123 -7.3322 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8028 -6.9272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0980 -7.3398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1035 -8.1543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9385 -8.1411 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20 1 2 0
1 2 1 0
2 4 2 0
3 21 2 0
3 4 1 0
1 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
20 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
3 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 349.43Molecular Weight (Monoisotopic): 349.1790AlogP: 3.84#Rotatable Bonds: 8Polar Surface Area: 74.25Molecular Species: BASEHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.62CX Basic pKa: 9.74CX LogP: 2.36CX LogD: 1.33Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.54Np Likeness Score: -0.85
References 1. Chen C, Yang X, Fang H, Hou X.. (2019) Design, synthesis and preliminary bioactivity evaluations of 8-hydroxyquinoline derivatives as matrix metalloproteinase (MMP) inhibitors., 181 [PMID:31415980 ] [10.1016/j.ejmech.2019.111563 ]